I've spent 30 years on the other side of this problem. As the commercial executive at companies like mPulse Mobile, I was the person walking into health plan boardrooms, navigating Medical Affairs committees, and closing enterprise contracts with 18 of the top 20 national health plans. I've seen what works. And I've watched hundreds of promising digital health companies fail to close a single plan — not because their product wasn't good, but because they fundamentally misunderstood how health plans make buying decisions.
If you're a Series A or B digital health founder struggling to convert payer interest into signed contracts, this is for you.
The Core Misunderstanding: Health Plans Are Not Buyers. They Are Risk Committees.
Early-stage companies almost always approach health plans the way they'd approach any enterprise software buyer: build a compelling demo, quantify ROI, get to the economic buyer, and close. That model works in SaaS. It doesn't work in payer sales.
A health plan purchasing decision touches Medical Affairs, Pharmacy, IT, Compliance, Legal, Actuarial, and the C-suite — often simultaneously. No single person can say yes. But any single person can say no. If you're only engaging one or two of these stakeholders, you're not in a sales process. You're in a waiting room.
The companies that close plans quickly have learned to treat payer sales as multi-threaded relationship development — not linear pipeline management.
The Five Mistakes I See Most Often
Leading with clinical outcomes instead of plan economics
Clinical evidence matters. But a VP of Population Health is evaluated on MLR, Star ratings, HEDIS performance, and member retention — not clinical abstracts. Lead with PMPM impact. Lead with projected MLR reduction. Lead with the Star measure your solution moves.
Pursuing too many plans at once with no prioritization framework
I've seen Series A companies with active "conversations" at 25 health plans and closed contracts at zero. More payers in your pipeline does not mean more revenue. Prioritize ruthlessly: which plans have the highest concentration of the population your solution serves? Which have budget cycles aligned to your timeline? Which have internal champions you can actually name?
Proposing a pilot when the plan wants a program
Health plans don't want to manage another pilot. Walk in with a program design that has a pilot phase built in — but make it clear you're selling a program, not an experiment.
Relying on warm intros without building institutional relationships
A warm intro gets you a first meeting. It does not get you a contract. If your champion leaves, moves roles, or goes on leave, and you have no other threads inside that plan, your deal dies with them. Build wide. Redundancy in relationships is not inefficiency — it's risk management.
Mispricing the solution relative to how plans measure ROI
If your PMPM is higher than what the plan can model as savings in Year 1, the deal goes to Legal and never comes out. Price your solution to be a no-brainer in the first year model, then grow the contract through performance-based structures and PMPM escalators at renewal.
What the Companies That Close Plans Actually Do Differently
- They have a dedicated commercial leader who has done this before — someone who knows which plans are buying, which are in budget freeze, and who the actual decision-makers are by name.
- They speak fluent payer economics. Every conversation is anchored in MLR, Stars, HEDIS, or risk adjustment.
- They bring a reference plan to every meeting. Nothing closes a health plan faster than another health plan saying it works.
- They close on outcomes-based structures. When you share the risk, you remove the plan's biggest objection.
- They have a multi-year account strategy for each target plan — not a single deal, but a relationship roadmap.
Why a Fractional Commercial Leader May Be the Right Move Right Now
Hiring a full-time CRO or CGO is a $300,000–$500,000 annual commitment before equity. A fractional commercial leader gives you the experience of a seasoned CRO — the relationships, the playbooks, the payer sales intuition — at a fraction of the cost, and without the long onboarding ramp.
The question isn't whether you need commercial leadership. If you're Series A or B and selling into health plans, you absolutely do. The question is whether this is the right moment to hire full-time, or whether a fractional engagement gets you to the milestones that make that full-time hire a much easier decision.
Let's Talk About Your Pipeline
If you're a Series A or B digital health company navigating health plan sales — or trying to figure out why your pipeline isn't converting — I'd be glad to spend 30 minutes on it.
Schedule a Call →